ECCO2017: 27-30 January, 2017 Amsterdam, The Netherlands
To those who have yet to register: The 28th November is the deadline of the REGULAR RATE registration. Hurry up and benefit from the reduced registration fees.
Why pay more when you can pay less?
Reasons to attend:
ECCO2017 is the only truly multidisciplinary oncology Congress in Europe.
You will learn about the most recent developments in monodisciplines from a multidisciplinary perspective and you will find out how these developments impact your clinical practice.
The Congress is annual so your interdisciplinary clinical knowledge is always up-to-date.
You benefit from top-notch educational programmes developed by a leading team of multidisciplinary experts.
You are a part of the hot discussions on the cost and organisation of cancer care in Europe.
You are in the right place for multidisciplinary networking with peers from Europe and the world.
European Cancer Congress 2017 has been granted 21 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).
You can grow in your career through leadership programmes, targeted ECCO member societies’ programmes and much more.
Interested? Read on to learn more...
Hear the latest trial data from a multidisciplinary perspective
Listen to principal investigators present data from key practice-changing trials and real-world studies across the main tumour types—breast, colorectal, head and neck and thoracic cancers—and also less commonly encountered tumour types and palliative/supportive care, in Clinical Symposia. Take part in the Critical Review Sessions, designed to define the real impact of clinical trials on daily practice and patient outcome. Hear a multidisciplinary panel review and critically assess the trial data and then join your peers from multiple disciplines to vote on whether you think the results are truly practice changing. Look at the full searchable programme to find out more about the Clinical Symposia and Critical Review Sessions taking place throughout the Congress (28–30 January).
Handling difficult cases – learn from the experts Find out how leading global experts—including authorities in medical, surgical and radiation oncology; pathology; oncology nursing and psychology—would manage challenging cases in a range of tumour types. These sessions provide a valuable opportunity to learn from the insights and experiences of specialists in their fields. Look at the full searchable programme to find out more about the Multidisciplinary Tumour Board Sessions taking place throughout the Congress (28–30 January).
And remember – this is your chance to showcase your own work and discuss it with your peers from all disciplines: